Anticoagulant (COVID-19)

Warning

exp date isn't null, but text field is

Anticoagulant switching from warfarin to DOACs, see: Royal Pharmaceutical Society Guidance for the safe switching of warfarin to direct oral anticoagulants (DOACs) for patients with non-valvular AF and venous thromboembolism (DVT / PE) during the coronavirus pandemic.
MHRA advice: Warfarin and other anticoagulants – monitoring of patients during the COVID-19 pandemic (October 2020) (www.gov.uk).

Last reviewed: 31 October 2020

Next review: 30 April 2021

Author(s): Patient Services Pharmacist

Version: 1

Approved By: Awaiting approval by CRG

Reviewer Name(s): Cardiology Department

Document Id: COVID102